Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/14/2005EP1572181A2 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor and the use of said composition for treating bladder dysfunction
09/14/2005EP1572180A1 USE OF a-PHENYLTHIOCARBOXYLIC AND a-PHENYLOXYCARBOXYLIC A CIDS WITH SERUM-GLUCOSE-LOWERING AND SERUM-LIPID-LOWERING ACTIVITY
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572178A2 Treatment of mastalgia with 4-hydroxy tamoxifen
09/14/2005EP1572177A1 Compositions and methods for treating upper respiratory congestion
09/14/2005EP1572176A2 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
09/14/2005EP1572175A1 Formulation, which can be administered gastrointestinally, containing green tea extract and an no donor
09/14/2005EP1572174A1 Prevention and treatment of alzheimer's disease
09/14/2005EP1572173A1 Alpha-2-delta ligand to treat lower urinary tract symptoms
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572171A2 Reduction of breast density with 4-hydroxy tamoxifen
09/14/2005EP1572170A2 Immunotoxin as a therapeutic agent and uses thereof
09/14/2005EP1572167A1 Transdermal buprenorphine dosage regimen for analgesia
09/14/2005EP1572166A1 Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor, e.g. parecoxib, valdecoxib and benzopyran derivatives
09/14/2005EP1572165A1 New film coating
09/14/2005EP1572164A2 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
09/14/2005EP1572163A1 Controlled-release of an active substance into a high fat environment
09/14/2005EP1572160A2 Process for manufacturing sustained release microbeads containing venlafaxine hci
09/14/2005EP1572159A1 Stable topiramate formulations
09/14/2005EP1572158A1 A new oral immediated release dosage form
09/14/2005EP1572157A1 Formulation for fast dissolution of lipophilic compounds
09/14/2005EP1572156A1 Process for preparing combination pharmaceutical formulations using supercritical fluids
09/14/2005EP1572152A2 Liposomal analgesic formulation and use
09/14/2005EP1572151A1 Liquid dosage forms of proton pump inhibitors
09/14/2005EP1572129A2 Amidine derivatives for treating amyloidosis
09/14/2005EP1572128A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/14/2005EP1572127A2 Enzyme treatment of foodstuffs for celiac sprue
09/14/2005EP1572124A2 Hcv e1e2 vaccine compositions
09/14/2005EP1572122A2 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
09/14/2005EP1572114A2 Glycosylceramide analogues
09/14/2005EP1572113A2 Calcium receptor modulating compound and use thereof
09/14/2005EP1572106A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
09/14/2005EP1572103A2 Anti-angiogenic uses of il-6 antagonists
09/14/2005EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
09/14/2005EP1572101A2 Disease treatment via antimicrobial peptide inhibitors
09/14/2005EP1572098A2 Method of treating snoring and other obstructive breathing disorders
09/14/2005EP1572097A2 Nucleoside derivatives for treating hepatitis c virus infection
09/14/2005EP1572095A2 S-l-2 -deoxynucleosides for the treatment of resistant hbv strains and combination therapies
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572089A2 Method for growing human organs, treating diseases, and increasing longevity
09/14/2005EP1572086A2 Methods and composition based on discovery of metabolism of nitroclycerin
09/14/2005EP1572083A2 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572075A2 Method for treating diseases associated with abnormal kinase activity
09/14/2005EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572070A2 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
09/14/2005EP1572067A2 Conjugates and compositions for cellular delivery
09/14/2005EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/14/2005EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/14/2005EP1571926A1 Use of prebiotics for preventing or treating oxidation stress
09/14/2005EP1571909A2 Optimized multi-epitope constructs and uses thereof
09/14/2005EP1529048A4 Methods for the synthesis of substituted purines
09/14/2005EP1515698A4 Liposomes containing biologically active compounds
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1461318B1 Tetrahydroquinoline analogues as muscarinic agonists
09/14/2005EP1460998A4 Extended release pharmaceutical tablet of metformin
09/14/2005EP1438060A4 Prevention and treatment of restenosis by local administration of drug
09/14/2005EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48
09/14/2005EP1401432B1 Imidazole derivatives for modulating sodium channels
09/14/2005EP1399157B1 Combination comprising a p-gp inhibitor and an anti-epileptic drug
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005EP1385834B1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
09/14/2005EP1363651B1 Herbal compositions useful as chemopreventive and therapeutic agents
09/14/2005EP1341781B1 Antimicrobial quinolones
09/14/2005EP1296700B1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root
09/14/2005EP1294373B1 Pharmaceutical disinfectants comprising usnic acid and essential oils
09/14/2005EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1274446B1 Polysaccharidic esters of n-derivatives of glutamic acid
09/14/2005EP1274445B1 Use of steroidal alkaloids to reverse multidrug resistance
09/14/2005EP1258250B1 Nerve protective drugs
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1218366B1 Method for producing cox-2 inhibitors
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005EP1140009B1 Absorbent article composition and use thereof for sequestering skin irritants.
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005EP1072268B1 Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof
09/14/2005EP1071420B1 Indolyl-3-glyoxylic acid derivatives with antitumoral activity
09/14/2005EP1051179B1 Anti-estrogen plus progestin containing oral contraceptives
09/14/2005EP1001793B1 Chromium/biotin treatment of type ii diabetes
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005EP0970081B1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
09/14/2005EP0904283B1 Human netrin-1
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1669183A Method and unit for beam control of antenna array
09/14/2005CN1668762A Sgk and Nedd used as diagnostic and therapeutic targets
09/14/2005CN1668761A Therapeutic use of selective PDE10 inhibitors
09/14/2005CN1668759A Method of searching substane having antidiabetic activity
09/14/2005CN1668755A Galactosyl isomalt, method for production and use thereof
09/14/2005CN1668750A Her-2/neu DNA vaccine having anti-cancer activity
09/14/2005CN1668741A Production of polyketides and other natural products
09/14/2005CN1668735A Method of utilizing physiological activity of rare saccharide and compositions containing rare saccharide
09/14/2005CN1668733A Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
09/14/2005CN1668732A Treatments with autologous fibroblast
09/14/2005CN1668721A Immunoadhesin comprising a glycoprotein VI domain
1 ... 4544 4545 4546 4547 4548 4549 4550 4551 4552 4553 4554 4555 4556 4557 4558 4559 4560 4561 4562 4563 4564 ... 7860